Abstract:Glucocorticoid (GC) has been shown to affect the neuronal survival/death through a genomic mechanism, but whether or not it does through a nongenomic mechanism is unknown. Using a previously identified GR-deficient primary hippocampal neuron culture, we show here that a 15-min coexposure of N-methyl-D-aspartate (NMDA) with corticosterone at a stress-induced level significantly enhances neuronal death compared to NMDA alone. This enhancing effect of GC can be mimicked by the BSA-conjugated corticosterone, which is plasma membrane impermeable and cannot be blocked by RU38486 spironolactone. Furthermore, using a calcium-imaging technique, we found that B could increase both the percentage of neurons showing a significant increment of intracellular free calcium ([Ca2+](i)) due to NMDA stimulation and the amplitude of [Ca2+](i) increment in the individual responsive cells. Interestingly, this boosting effect of GC on [Ca2+](i) increment could be blocked by the NMDA receptor subunit 2A (NR2A)-specific antagonist [(R)-[(S)-1-(4-bromo-phenyl)-ethylamino]-(2,3-dioxo-1,2,3,4-tetrahydro-quinoxalin-5-yl)-methyl]-phosphonic acid (NVP-AAM077) but not by the NMDA receptor subunit 2B (NR2B)-specific antagonist Ro25-6981. Moreover, we also found that GC can dramatically attenuate the NMDA-induced activation of ERK1/2 without affecting that of p38; and that the NMDA-induced ERK1/2 activation and its attenuation by GC both can be occluded by the NVP-AAM077 but not by Ro25-6981. Consistently, the enhancing effect of GC on NMDA neurotoxicity can also be blocked by NVP-AAM077 and the ERK1/2 inhibitor PD98059 but not by Ro25-6981 and p38 inhibitor SB203580. Indeed, the NMDA neurotoxicity itself can be blocked by Ro25-6981 or SB203580, whereas it is increased by NVP-AAM077 and PD98059. Therefore, it is probable that NMDA triggers a prodeath signaling through the NR2B-p38 MAPK pathway, and a prosurvival signaling through the NR2A-ERK1/2 MAPK pathway, whereas the latter was negatively regulated by rapid GC action. Taken together, the present data suggest a nongenomic action by GC that enhances NMDA neurotoxicity through facilitating [Ca2+](i) increment and attenuating the NR2A-ERK1/2-mediated neuroprotective signaling, implicating a novel pathway underlying the regulatory effect of GC on neuronal survival/death.

Possible Genomic Consequence of Nongenomic Action of Glucocorticoids in Neural Cells

Pleiotropic Signaling Pathways in Rapid, Nongenomic Action of Glucocorticoid

Non-genomic mechanism of glucocorticoid's rapid action on neurons-membrane receptor hypothesis

Signal Transduction Pathway of Glucocorticoid’ S Rapid Action in PC12 Cells

Glucocorticoids modulate neural activity via a rapid non-genomic effect on Kv2.2 channels in the central nervous system

Why do we need nongenomic glucocorticoid mechanisms?

New Aspects of the Mechanisms of Glucocorticoid Actions on the Brain

Glucocorticoid Rapidly Enhances NMDA-evoked Neurotoxicity by Attenuating the NR2A-containing NMDA Receptor-Mediated ERK1/2 Activation.

Rapid Non-Genomic Inhibitory Effects of Glucocorticoids on Human Neutrophil Degranulation

[Physiological Significance of Nongenomic Mechanisms of Glucocorticoids].

A rapid, nongenomic action of glucocorticoids in rat B103 neuroblastoma cells.

Glucocorticoid Exerts Its Non-Genomic Effect on Ipsc by Activation of A Phospholipase C-Dependent Pathway in Prefrontal Cortex of Rats

Nongenomic effects of steroids on glycine uptake in L929 cells

Rapid Nongenomic Inhibitory Effects of Glucocorticoids on Phagocytosis and Superoxide Anion Production by Macrophages

Non-genomic Actions of Steroids: Mechanism and Significance

Rapid Activation of Jnk and P38 by Glucocorticoids in Primary Cultured Hippocampal Cells

A novel strategy for development of glucocorticoids through non-genomic mechanism

Modulation of Neuronal Nicotinic Acetylcholine Receptorsby Glucocorticoids

Cell-type specific impact of glucocorticoid receptor activation on the developing brain

Glucocorticoid action networks and complex psychiatric and/or somatic disorders

Polymorphisms in the Glucocorticoid Receptor Gene and Associations with Glucocorticoid-Induced Avascular Osteonecrosis of the Femoral Head.